April 09, 2026

Medical Oddities: Tattoos and Teeth Share Work Struggles

From unexpected workplace parallels to kitchen-counter experiments and a few clinical twists, this set of stories covered more ground than your average shift.

Conexiant

March 12, 2026

Medical Oddities: Allergies, Meet Your Match in Matcha

Matcha muting sneezes, snack foods nudging fracture risk, firstborns navigating baby-number-two drama, and more this week.

Conexiant

February 26, 2026

‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada

Workforce shortages on both sides of the border add urgency.

KFF Health News

January 15, 2026

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Conexiant

January 13, 2026

Clinical trial tests promising CAR T-cell therapy for lupus

UCI Health has launched a groundbreaking clinical trial for a next?generation CAR T?cell therapy.

UCI Health

December 12, 2025

Help Needed. Help Avoided. Here’s Why.

Many older Americans qualify for disability accommodations but reject the label — limiting access to care, support, and legal protections.

KFF Health News

December 09, 2025

Top 10 States to Practice Pediatrics

These 10 states offer pediatricians the strongest mix of high earning potential, low competition, and supportive practice environments—balancing salary, demand, and quality of life for providers at any career stage.

Conexiant

December 05, 2025

Fancy Gadgets, Higher Bills: HSA Era

Republican proposals to expand health savings accounts amid expiring ACA subsidies outline potential shifts in coverage costs and limitations in how patients may use HSA funds.

KFF Health News

December 05, 2025

Top 10 States to Practice Rheumatology

The following list highlights the states that offer the most favorable conditions for rheumatologists.

Conexiant

November 17, 2025

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

Conexiant